Mirae Asset Global Etfs Holdings Ltd. Tyra Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,182 shares of TYRA stock, worth $182,966. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,182
Previous 11,514
14.49%
Holding current value
$182,966
Previous $107,000
17.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TYRA
# of Institutions
120Shares Held
59.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$169 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$56.6 Million93.82% of portfolio
-
Nextech Invest Ag4.06MShares$56.3 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$56.3 Million7.35% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$54.7 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $583M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...